GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medistim ASA (OSTO:MEDIO) » Definitions » 3-Year EPS without NRI Growth Rate

Medistim ASA (OSTO:MEDIO) 3-Year EPS without NRI Growth Rate : 14.30% (As of Dec. 2023)


View and export this data going back to 2004. Start your Free Trial

What is Medistim ASA 3-Year EPS without NRI Growth Rate?

Medistim ASA's EPS without NRI for the three months ended in Dec. 2023 was kr1.04.

During the past 12 months, Medistim ASA's average EPS without NRI Growth Rate was -9.10% per year. During the past 3 years, the average EPS without NRI Growth Rate was 14.30% per year. During the past 5 years, the average EPS without NRI Growth Rate was 14.30% per year. During the past 10 years, the average EPS without NRI Growth Rate was 15.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Medistim ASA was 47.60% per year. The lowest was -12.30% per year. And the median was 13.50% per year.


Competitive Comparison of Medistim ASA's 3-Year EPS without NRI Growth Rate

For the Medical Devices subindustry, Medistim ASA's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medistim ASA's 3-Year EPS without NRI Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medistim ASA's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Medistim ASA's 3-Year EPS without NRI Growth Rate falls into.



Medistim ASA 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Medistim ASA  (OSTO:MEDIO) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Medistim ASA 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Medistim ASA's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Medistim ASA (OSTO:MEDIO) Business Description

Traded in Other Exchanges
Address
Okernveien 94, Oslo, NOR, 0579
Medistim ASA is a medical device company. It is engaged in researching, developing, producing, distributing and sales of medical equipment through its own business or through participation in other companies, as well related activities. The company's business is focused on cardiac and vascular surgery. The group operates in the USA, Europe, Asia and the Rest of the World. The firm's activity is split into three strategic operating units, Lease of equipment; Lease of equipment and Distribution and sales of third-party products.

Medistim ASA (OSTO:MEDIO) Headlines

No Headlines